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ABSTRACT 
 
Association between Sleep Disturbances and Suicidal Ideation among Opioids 
Abusers 
 
By 
Aditi Patel 
 
 
 
October 27 2017 
 
INTRODUCTION: Several previous studies have documented a relationship between sleep 
problems and suicide. However, this association has not been explored specifically among opioid 
users. Given that studies have suggested that opioids can interrupt sleep and that opioid users are 
more likely to attempt suicide than non-users, it is important to further investigate the association 
between sleep disturbance and suicidal ideation, planning, and attempts among opioid abusers.  
 
METHODS: Data from the National Survey on Drug Use and Health 2010-2014 survey were 
analyzed to assess whether there was an association between sleep problems and suicidal 
ideation, planning and attempts among individuals who report abusing opioid medications. 
Prevalence of opioids abusers by demographic characteristics, odds ratios and 95% confidence 
intervals unadjusted and adjusted by age, gender & mental health disorders were reported. 
 
RESULTS: Results indicated that opioids abuse was higher in ages 18 to 25 years. Results of 
2011 unadjusted and adjusted analyses showed significant associations between sleep 
disturbance and suicidal planning. Results of 2012 adjusted analyses showed significant 
associations between sleep disturbance and suicidal attempts. Results of 2013 unadjusted and 
adjusted analyses showed significant association between sleep disturbance and suicidal ideation 
among opioids abusers.  
 
DISCUSSION: This research provided some evidence of an association between sleep 
disturbances and suicidal ideations, planning and attempts among opioids abusers using NSDUH 
data. This study’s findings can be beneficial for educational and public health prevention 
programs to promote a better understanding of sleep disturbance, suicidal ideation, planning, and 
attempts among opioid abusers. More research can help to find risk factors and achieve overall 
mission of harm reduction among opioids abusers. 
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Association between Sleep Disturbances and Suicidal Ideation among Opioids Abusers 
 
Introduction: 
 
The United States (US) opioid epidemic is growing, and it is becoming an important 
community health issue in all states (Rudd, Seth, David & Scholl 2015). Drug overdose deaths 
increased by three times between 1999 and 2014; among those that occurred during 2014, 60.9% 
of these deaths involved opioids (Rudd et al., 2015) and six out of ten overdose deaths involve 
opioids as a leading cause of mortality. According to the recent Centers for Disease Control and 
Prevention (CDC) report, 91 Americans die every day from opioids overdose (Suicide Overdose, 
2016).  
According to Substance Abuse and Mental Health Services Administration (SAMHSA), 
the number of opioid prescriptions dispensed by US retail pharmacy increased from 76 million in 
1999 to 207 million in 2013. The US consumes nearly 100% of worldwide hydrocodone and 
consumes 81% of oxycodone. Treatment admissions for opioids abuse other than any other drug 
abuse increased from one percent of all admissions in 1997 to five percent in 2007. Prescriptions 
for medications such as oxycodone, hydrocodone, and methadone use have increased almost four 
times over the last 23 years, and there is a growing concern about opioid misuse in the US 
(Rudd, Seth, David & Scholl, 2015). The International Narcotics Control Board Report in 2008 
found that the number of hydrocodone prescription dispensed by US pharmacies increased from 
25 million to 124 million and for oxycodone increased from 12 million to 53 million between 
1999 to 2013. 
More than half of fifty states had increased rates of drug overdose deaths from opioids; 
decreased rates were attributed to policy changes regarding opioids in some states (Rudd et al., 
2015). According to National Institute on Drug Abuse (NIDA), people who become addicted to 
opioids take more and more of the same drug to get higher effects. Opioids abusers can overuse 
pain pills using their own prescriptions from doctors or use them for non-medical reasons even 
after they do not need pain pills left over from surgery or dental procedures. People with opioids 
addiction might steal medicines from loved ones, get them from a friend or buy them from a drug 
dealer. Opioids abusers are also more likely to shop around at different pharmacies to fill their 
multiple opioids prescriptions. Many risk factors lead people to abuse opioids and use it for non-
medical reasons just like any other types of disease occurring from risk factors. People who have 
a history of substance abuse disorders, different types of sleep-disordered breathing, and mental 
illness are more likely to abuse opioids than other individuals without these risk factors. Risk 
factors also lead people to abuse opioids and use it for non-medical reasons just like any other 
types of disease occurring from risk factors. People who have a history of substance abuse 
disorders, different types of sleep-disordered breathing, and mental illness disorders are more 
likely to abuse opioids than other individuals without these risk factors (Robinson et al., 2017).  
The abuse of prescription pain relievers by pregnant women can result in neonatal 
abstinence syndrome (NAS), and Anesthesiology report 2014 also showed 14.4 percent of 
pregnant women are prescribed an opioid during their pregnancy. Smith and Lipari (2017) found 
that an average of 21,000 pregnant women misused opioids in the past month using 2007 to 2012 
National Surveys on Drug Use and Health (NSDUH). Although opioid use is lower than non-
pregnant women in the same age group, it was still more common among pregnant women who 
live below federal poverty line (Smith & Lipari, 2017). Smith & Lipari (2017) also suggest that 
prevention and intervention efforts to reduce opioids abuse is necessary among 15-25 years old 
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women group because of that same age group also more likely to abuse opioids than their older 
counterparts.  
Bohnert et al.  (2013) study among addictions treatment patients for opioid use for 
reasons related to pain vs. for reasons other than pain relief can provide some insights on the 
nonmedical use of opioids among abusers. According to Bohnert et al. (2013) state that people 
use opioids for purposes other than pain relief for several reasons such as to receive 
pleasure/social enhancement, reduce emotional distress from depressive symptoms, and cope 
with negative experiences and emotions by using opioids. Bohnert et al. (2013) also reported the 
higher level of non-medical use of opioids for reasons other than pain among people who have 
prior drug overdose history, mental disorders, and other substance use history. (2013). Addiction 
treatment patients who abuse opioids for reasons other than pain also reported taking higher 
doses than people who use opioids for pain relief. There are also higher number points of in 
mental health problems disturbances among opioids abusers who use opioids drugs for 
nonmedical use for reasons other than pain (Bohnert et al., 2013).  
Major concerns are rising related to drug overdose deaths by opioids use (Cheatle, 2011). 
For example, previous studies involving opioid users suggest that there may be a relationship 
between sleep problems and opioids use (Bernert, 2008). This study is particularly concerning 
given that evidence suggests that there is a strong link between sleep disorders and suicide 
(Bernert, 2008). There is the possibility of an association between opioids use, sleep disturbance 
and suicidal ideation, planning, and attempts. However, this relationship has not been explored 
specifically among opioid users. Given that studies have suggested that opioids can interrupt 
sleep and that opioid users are more likely to attempt suicide than non-users, it is important to 
further investigate the association between sleep problems and suicidal ideation, planning, and 
attempts in this population. The purpose of this research is to explore the relationship between 
sleep disturbance and suicidal ideation, planning, and attempts among opioid abusers. 
Specifically, the following research questions are addressed:  
(1) What is the association between sleep disturbance and suicidal ideation, suicide 
planning and attempts among opioid abusers reported in the National survey on Drug Use and 
Health (NSDUH) dataset from 2010 to 2014?  
(2) How do the associations between sleep disturbance and suicidal ideation, planning 
and attempts among opioid abusers progressing throughout years 2010 to 2014 NSDUH dataset 
change over time?  
 
Understanding the association between sleep disturbance and suicidal ideation may help 
doctors and other healthcare professionals who work with people who use opioids to understand 
the phenomenon of opioid abusers’ higher risk of sleep disturbance, suicidal ideation, planning 
and attempts, and death from opioid overdose.  
 
Quantifying the association using NSDUH data from 2010-2014 will provide significant 
opportunity to intervene in the drug overdose epidemic among abusers. In a further literature 
review, we will examine opioid addicts’ demographics and characteristics, opioids effects on the 
human brain, opioids and sleep disturbance, opioids and suicidal ideation, planning, and 
attempts, sleep disturbance and suicidal ideation, planning, and attempts. We will also further 
examine the framework of opioids abusers, sleep disturbance, and suicidal ideation, planning, 
and attempts in a given national survey on drug use and health data set to point out the findings 
in data analysis. 
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Literature Review: 
 
Epidemiology of chronic pain in the US 
 
Opioids are commonly prescribed because they are effective in relieving many types of 
pain. Among these many types of pain, the National Institute of Health Statistics survey 
indicated that low back pain was the most common (27%), followed by a severe headache or 
migraine pain (15%), neck pain (15%) and facial ache or pain (4%). Adults with low back pain 
are often in worse physical and mental health than people who do not have low back pain. 
According to the same survey which concluded low back pain was the leading cause of pain, 
they also reported 100 million Americans are experiencing chronic pain. Freburger et al. also 
suggested that lower back pain prevalence increased over the 14 years- interval, from 3.9% in 
1992 to 10.2% in 2006. Increases were seen for all adult ages, males, and females and black and 
white races.  Since 1999, an increasing number of Americans are receiving prescription opioids 
for their pain, but they are still reporting the same level of pain as before. According to Barbour 
et al., the number of American reported severe joint pain in health survey done by CDC was 10.5 
million in 2002, and that same number increased to 14.5 million in 2014 (2016).  The Morbidity 
and Mortality Weekly Report (MMWR) report on Prevalence of Severe Joint Pain Among 
Adults with Doctor-Diagnosed Arthritis between 2002 and 2014 also estimate that the prevalence 
of arthritis among US adults is expected to grow 52.5 million in 2010-2012 to 78.4 million by 
2040 (Barbour et al., 2016).  
According to Robinson et al. (2017) chronic pain affect approximately 100 million 
Americans, and sociodemographic, medical history, healthcare access and utilization, self-
management barriers, and social support affect how people manage chronic pain. Among chronic 
pain population in the USA, middle-aged and older adults make up 80% of prevalence, and they 
are more vulnerable than any other group.  As earlier stated, factors such as sociodemographic, 
medical history, healthcare access and utilization, self-management barriers, and social support 
are same factors which more likely to affect minorities and women and also affect chronic pain 
effects (Robinson et al., 2017). According to 2009 National Health Interview Survey, women 
were twice as likely to experience migraines (severe headaches), or pain in the face or jaw than 
men. Johannes et al. (2010) also found some of the subgroups report experiencing pain more 
than others in their internet based survey. Ages 55 to 65 years old three times more likely to 
experience pain than youngest age group 18-24 years old (Johannes, Le, Zhou, Johnston & 
Dworkin, 2010). People with low income, unemployed with disability and females are 20% more 
likely to experience chronic pain than any other group (Johannes et al., 2010).  There are 
approximately 100 million people have chronic pain in America, and the even small number of 
those people become addictive to opioids have a serious effect on population health (Volkow, 
2014). Opioids also produce a feeling of well-being and pleasure among users, and it directly 
affects the rewards part of the brain. Those effects are similar to some illegal drugs such as 
heroin. Studies on opioids use support evidence based findings on opioids abuse leading to 
heroin epidemic in certain areas of the US (Volkow, 2014).  
 
Definition of opioids 
 
Opioids are a class of medications which are specifically designed to treat pain and can 
be highly addictive. Opioids are naturally occurring from the opium poppy plant, semi-synthetic 
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ones from natural plants as stating materials and mixing chemical synthetic and synthetic ones 
are from total synthetic and petrochemical building blocks (National institute on Drug Abuse 
(NIDA), 2017). According to NIDA, the definition of opioid abuse is taking pain prescription 
drugs in a dose other than prescribed, using someone else’s prescription and taking them to get 
high. Opioids are very effective to treat pain for a short time by taking as prescribed by doctors. 
Misused opioids can lead to more dependence and addiction (NIDA, 2017). According to 
American Society of Addiction Medicine, addiction is one of the chronic brain reward diseases. 
Addiction’s effects such as the inability to abstain, mental impairment, craving, diminished 
thinking and dysfunctional emotional response make opioids more harmful and opioids abusers 
to more vulnerable to problems such as overdose deaths and injuries.   
 
Epidemiology of opioid use 
 
According to Volkow and McLellan, more than 30% of Americans have some form of 
chronic and acute pain, and among old Americans, the prevalence of chronic pain is 40% (2014). 
Opioids are more frequently dispensed in US retail pharmacies now than 20 years before.  
Volkow and McLellan also found that US retail pharmacies dispensed 85 million prescriptions 
for opioids in 1994 compare to recent data about 245 million prescriptions for opioids in 2014. 
The study also found that 65% of that prescription was for short-term opioids therapy and 9.6 
million to 11.5 million of the adult population are on longer-term opioid therapy (Volkow & 
McLellan, 2014).  
As a result of the increased use of opioids in the US, there has also been an increase in 
the number of deaths related to opioid use/abuse. Thirty-seven percent of the 44,000 drug 
overdose deaths were from opioids use compared to 19% of heroin-related deaths in 2013. The 
overdose deaths from opioids are due to the current epidemic of opioids abuse. Volkow and 
McLellan stated that there were 2.5 million adults were affected by opioids overdose in 2014.  
Volkow and McLellan (2016) also stated that heroin is typically cheaper than opioids and it is 
easier to obtain in some instances. Opioid users often transition to heroin abuse (Volkow & 
McLellan, 2016). There is a relatively small percentage (4%) of addicted persons who transition 
to heroin according to Volkow and McLellan (2016) findings; however, that number is growing. 
The main source of opioids are prescriptions written by physicians, and some of the physicians 
and medical associations also released specific guidelines for prescribing opioids and managing 
chronic pain. Opioids misuse often times results from patients seeking prescriptions by “doctor-
shopping” or going to different pharmacies (Volkow & McLellan, 2016). Many physicians also 
admitted that they do not know how to prescribe opioids safely, how to detect abuse or addiction, 
and even how to educate their patients about side effects of opioids use (Volkow & McLellan, 
2016). 
The study by Volkow & McLellan (2016) also found that addicted patients who abstained 
from opioids for sometimes, they also have some risk for an opioids overdose. Discontinuation 
of opioids reverse the tolerance and physical dependence within days or weeks, but the 
underlying effects of addiction stays for years among opioids users (Volkow & McLellan, 2016).  
Overdose risk in prisoners after getting out of jail and people who come out of detoxification 
program is higher, so early interventions among opioids users are necessary to solve problems 
related to opioid abuse (Volkow & McLellan, 2016).  
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Demographic Characteristics of Individuals Who Abuse Opioids 
 
According to Zacny et al. (2003), non-medical use of opioids leads to psychological 
effects such as impairment or distress, social and interpersonal problems, substance dependence 
from addiction effects and suicide attempts. Non-medical use of opioids may lead to different 
types of physical and social problems for opioids abusers. According to the CDC opioids drug 
overdose report, most of opioids abusers have common characteristics such as obtaining multiple 
prescriptions for opioids, taking high doses of opioids, mental or substance abuse disorders and 
living in a rural low-income household (2016). The shared characteristics stated above suggest 
that suicides can be possible by attempting to get high and leading to deaths from overdose 
among same group (Zacny et al., 2003). Most of the times opioids abusers also try to attempt 
suicide using drugs in high dose. There is also a similarity between them for higher risk of 
overdose and suicide. Often, individuals who abuse opioids also have substance abuse disorders. 
The drug overdose report by CDC also suggested that individuals with addiction disorders have a 
higher risk of the drug overdose (2016). For this research purpose, it will be important to 
examine characteristics of opioids users’ such as gender, mental health, alcohol abuse, other 
substance use, sleep problems, and suicidal idealization to get a better understanding of the 
association between sleep and suicide among opioids abusers.   
According to Tordoff and Ganty, there are three types of major characteristics seen 
among opioids abusers (2010). Pseudo-addiction is one the characteristics among opioid users 
when their pain is untreated or not treated with the right dose of opioids. Untreated pain and 
patient’s fear of recurring pain can lead to illegal drug use and often time these characteristics is 
mistaken for addiction among opioid users (Tordoff & Ganty, 2010). The second characteristic is 
dependence resulting from the continuous use of opioid prescriptions and resulting tolerance and 
withdrawal symptoms from reduced dose. Dependence is to prevent physiological withdrawal, 
where addiction is the continued use of the drug, despite its harm. Third type of characteristics is 
tolerance among opioids users to either its therapeutic effects or its unwanted side effects. 
Tolerance can make opioids users to increase their dose and craving for opioids more.  Findings 
from Enevoldson suggests that opioid addicts are more likely to experience sleep problems and 
suicidal ideation (2004). Nonmedical use of opioids can also lead to panic, depressive, and 
psychiatric symptoms.  Trémeau et al. (2008) found that opioids use contributes to low serotonin 
level in brain, which can contribute to the risk of addiction, sleep disorders and suicide ideation 
(2008).  
 
Risk factors for/predictors of opioid abuse 
 
     Cochran et al. (2014) examined commercial insurance claims data to differentiate and 
elucidate predictors of opioid abuse or dependence diagnoses within two years of filling an 
opioid prescription from those who do not receive such a diagnosis within the same time frame. 
The researchers found that individuals with interpersonal problems, use of multiple opioids, use 
for non-identifiable reasons, and comorbidity with other substance misuses were significant 
predictors of opioid abuse and dependence disorders (Cochran et al., 2014). Previous studies 
have also suggested that there may be a link between nonmedical use of prescription drugs and 
mental health disorders (Cochran et al., 2014). Long term opioids abuse and dependence largely 
contributed by non-opioid substance use and mental health disorders (Cochran et al., 2014). 
Many mental health diagnoses are one of the major risk factors for opioids misuse, but often 
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people hide mental health problems due to stigma in society. Misdiagnosis can lead to opioid use 
rather than appropriate psychiatric medication (Cochran et al., 2014). Opioids users were also 
more likely to have anxiety, mood, pain, personality disorders, and other kinds of psychotic 
disorders; these characteristics may lead them to abuse and become more addicted to opioids. 
57.7% of opioid users had another substance use disorder diagnosis compared to 3.4% of 
nonusers. Cochran et al., study found 20.7% alcohol dependence, 16.3% other, mixed, or 
unspecified drug abuse, 7.1% cocaine dependence among opioids users compared to 0.5%, 0.1%, 
and 0.0% among nonusers. These findings are useful to identify opioid abuse characteristics 
among people who use opioids for medical purposes (Cochran et al., 2014).   
Volkow and McLellan also suggest that one critical issue for treating pain patients is 
identifying their risk for abusing pain prescriptions (2016). All prescribers should know risk of 
diversion, overdose, and addiction among opioids users. Volkow and McLellan (2016) also 
found that not all medical schools have proper curriculum on pain and addiction treatment. Long 
term treatment of opioids has questionable benefits and more public health risk. Providers who 
have gap in knowledge about opioids long term treatment, their patients are at more risk for 
opioids abuse (Volkow & McLellan, 2016). According to Volkow and McLellan, abuse risk is 
greatest when the individual has risk factors in all three categories (psychosocial factors, drug-
related factors, and genetic factors) (2016).  In the absence of psychosocial and genetic risk 
factors, opioids users are less likely to develop the addiction. At the same time, the individual 
with a history of substance abuse and psychosocial comorbidity are at increased risk, especially 
if treatment with opioids is not monitored by physicians (Volkow & McLellan, 2016). 
 
Consequences of opioid use and abuse  
 
Several research studies suggested sleep disturbance and suicidal ideation as 
consequences of opioid use and abuse. According to Cheatle (2011), comorbid depression poses 
the greater risk for suicide among people living with pain (2011). It is almost impossible to 
determine the number of failed and successful suicides among opioids users because opioids 
abuse also leads to overdose. After deaths from overdose, it will be hard to determine if it was 
intended or unintended among opioids abusers (Cheatle, 2011). Evidence suggests that there is a 
higher risk for suicide among opioids users and support the fact that some overdose deaths from 
opioids are intended suicide attempts. The number of opioid-related poisoning increased from 
4,000 to 13,800 deaths from 1999 to 2006 and among that 40% of deaths involved opioids use 
(Cheatle, 2011). Opioid-related fatal poisonings also support the increased availability of written 
prescription of opioids from clinicians. Results from the 2010 SAMHSA also states that 
emergency department visits for drug-related suicide attempts increased by 30% and there was a 
55% increase in opioid-related attempts between 2005 and 2007. Cheatle (2011) also stated that 
committing suicide is a way out for a situation or problem that is causing the extreme problem. 
In 2007, 1 in 5 individuals who have been admitted to the ER for suicide-related injury showed 
evidence for using prescription opioids (Cheatle, 2011). Risk factors for suicide include the 
family history of suicide, history of childhood abuse, previous suicide attempts, history of mental 
disorders, history of alcohol and substance abuse, aggressive behaviors, social and work 
isolation, fear of seeking help (Cheatle, 2011).  Factors such as frequency of suicidal ideation, 
poor social support system, being unemployed, being divorced, suffering from chronic illness, 
and having psychiatric disorders can also lead to suicide. Chronic illness and pain lead to the 
feeling of hopelessness, and resulting frustration, anxiety and loss of control can lead to thinking 
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suicide is an easy way out for chronic patients (Cheatle, 2011). According to Franklin (2014), 
there has been the major shift in science and policy regarding opioids prescription during the 
1980’s to recognize pain as a vital sign, and it is directly or indirectly responsible for increased 
prescriptions dispensed by US retail pharmacies and it affected 100,000 deaths from opioids use 
to date. The use of prescription opioid medications has increased greatly in the US during the 
past two decades; in 2010, there were 16,651 opioid-related deaths. The Drug Abuse Warning 
Network also reported 183% increased medical emergencies related to opioids from 2004 to 
2011(Dart et al., 2015).   
According to Hassett, Aquino and Ilgen (2014), there have been 38000 suicide deaths in 
2010 associated with opioids, and for every death, approximately 25 suicide attempts led to 
personal injury. In Hassett, Aquino and Ilgen (2014) study, patients experiencing pain expressed 
the desire to die to end the pain compared to individuals without pain. Hassett, Aquino, and Ilgen 
(2014) report that suicide mortality is associated with greater severity of pain, after controlling 
demographic factors, health status, physical functioning, medical comorbidities, sleep duration, 
alcohol consumption, body mass index, smoking, and psychological stress factors. Another study 
among 260,254 veterans also found 45.27 suicide rate in 100,000 person-years with very mild 
pain and a rate of 80.65 suicide rate in 100,000 veterans with very severe pain after controlling 
all factors including psychiatric factors (Hassett, Aquino, & Ilgen, 2014). Therefore, evidence 
suggests that individuals experiencing pain are more likely to express suicidal ideation compared 
to individuals without pain.   
 Some studies suggested the need of intervention for suicide among opioids users because 
evidence suggests they are five times more likely to commit suicide and their risk of suicide is 
double that of individuals who are not taking opioids (Hassett, Aquino, and Ilgen, 2014).  
Greater pain increases the risk of mortality related to suicide. The presence of Psychiatric 
Comorbidity also plays an important role in leading suicide. In the study, 31.0 % of chronic pain 
patients with anxiety expressed suicidal ideation compared to 13.0 % of chronic patients without 
anxiety (Hassett, Aquino, & Ilgen, 2014).  Pain is still the independent factor, but analysis of 
other substance use is also necessary to prevent suicide mortality among chronic patients. 
According to Hooley, Franklin, and Nock (2014), more than 1 million die by suicide each year 
due to some major risk factors responsible for completed suicidal attempts leading to deaths. 
Risk factors for include older age, male sex, previous suicide attempts, and the presence of 
psychiatric problems. For opioids users, chronic pain is the one of the big factor leading to 
suicide because Hooley, Franklin, and Nock (2014) pointed out depression, emotional pain, 
desire to escape pain, increased capabilities for suicides, and burdensomeness for belongings 
from chronic pain leads to suicide behavior anxiety and hopelessness. According to Cheatle and 
Webster, the study among pain treatment for a particular subgroup of patients with non-cancer 
pain do experience adverse side effects from opioid therapy (2015). Side effects include 
addiction, sleep disorder, cognitive difficulties, sedation and bladder dysfunction. These factors 
often lead to the lack of sleep and suicide attempts (Hooley, Franklin, & Nock, 2014).  
 
Literature on association between chronic pain, opioid use and sleep disturbance  
 
According to Finan, Goodin, and Smith, pain greatly influences neurons in the 
hypothalamus the part of the brain responsible for behavior by sending a physical and emotional 
signal of harm (2013). Sleep is regulated by the same part of the brain which controls pain 
signals and behaviors, and sleep also can maintain physiologic systems of the body. Finan, and 
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colleagues suggest that 67-88% of people with chronic pain disorders complained about sleep 
and diagnosed insomnia was present among 50% of chronic patients (2013). Chronic pain and 
sleep disturbances share some of the common comorbidities such as depression, obesity, and 
type 2 diabetes. Development of pain and sleep disturbances indirectly affect each other one way 
or another way. Prospective studies have suggested that lack of sleep also increases pain 
sensitivity among people and loss of sleep causes nociceptive stimuli (Finan, Goodin, & Smith, 
2013).  
Angarita, Emadi, Hodges, & Morgan, (2016) also found that dizziness and sleepiness are 
common side effects of opioids, and even short-term opioid use leads cognitive effects such as 
the ability to make the judgement about the unnecessary use of opioids among chronic pain 
patients. Not only initial use, but withdrawal and abstinence from opioids affect sleep same way 
by showing effects of increased sleep latency, reduced sleep duration, insomnia, inadequate sleep 
quality and quantity and increased drowsiness. Even a single dose of opioids interrupt sleeping 
patterns among healthy adults. For example, in one recent study, an electrical scan of the brain 
showed the difference between total sleep time, sleep efficiency, sleep latency, total time awake, 
and time spent moving among opioid users and nonusers (Angarita et al., 2016). Several 
cognitive abnormalities caused by breathing patterns and oxygen intake among people who use 
opioids also lead to sleep disturbances. Past research has suggested depressive and anxious 
symptoms, nicotine use, pain, and unemployment are major risk factors for poor sleep quality 
and opioids users have all of those characteristics most of the time (Angarita et al., 2016). There 
is need to identify risk factors associated with individual’s sleep disturbances to avoid side 
effects caused by sleep disturbances among opioids users. Better management of sleep 
disturbance among opioids users by healthcare providers can stop the harm caused by lack of 
sleep.   
Several previous studies found that patients with chronic pain can experience sleep 
disorder in the long term. There is also a scientific debate about whether opioids have beneficial 
or harmful effects on sleep quality and efficiency (Cheatle & Webster 2015). Sleep disordered 
breathing is sleep related breathing problems and irregular breathing during sleep. A sleep 
disorder can create a headache, irritability and mood swings, and it can sleep disorder can lead to 
unintentional opioid overdose attempts among opioids users. According to Cheatle & Webster, 
the study among pain treatment for a particular subgroup of patients with non-cancer pain do 
experience adverse side effects from opioid therapy (2015). Side effects include addiction, sleep 
disorder, cognitive difficulties, sedation and bladder dysfunction. In the non-cancer patient study, 
there are greater than 50% of participants reported sleep disorder. Sleep disturbance leads to poor 
sleep quality among opioids users, and it can increase their pain intensity (Cheatle & Webster, 
2015). Cheatle and Webster also found that there is evidence of sleep disordered breathing from 
opioid use and it is one of a risk factor for drug overdose (2015). So far, there are clear paths 
leading sleep disturbance to suicide and opioids leading to suicide.  
 
Literature on association between chronic pain, opioid use and suicidality  
 
Suicidal ideation is a continuous process of negative feelings, thoughts and plans.  
Prevalence of suicidal ideations, thoughts, and plans are very hard to estimate, but often time 
non-fatal suicide attempt finally leads to death by fatal suicide (Arribas-Ibar, Suelves, Snachez-
Niubo, Domingo-Salvany, & Brugal, 2017). Suicide-related deaths represent 15% of total 15,000 
fatal injuries occur daily and among 15-29 years old suicide is the second leading cause of death. 
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Mental disorder greatly affects the rate of suicide, but several research studies also suggested that 
opioid use may increase the likelihood of fatal and non-fatal suicidal behavior. Drug users more 
likely to experience traumatic experiences such as drug-scene crime events, illegal drug market 
activities, being in prison and it also contributes to developing ideations about suicide attempts 
and planning (Arribas-Ibar et al., 2017). Arribas-Ibar et al.’s study also found 32.7% prevalence 
for suicidal ideation among illicit drug users in the treatment facility is much higher than the 
general population (2017). Suicide is one of the factors leading to high rate of morbidity and 
mortality among drug users. The presence of mental disorders, history of trauma, previous 
suicide attempt and stressful events also significantly contribute to suicidal ideation among 
opioid users (Arribas-Ibar et al., 2017).  
Ilgen, Zivin, Mccammon & Valenstein (2008), also suggested that chronic pain is 
associated with depression, anxiety, alcohol and drug abuse or dependence (2008). The 
relationship between pain and suicide is also suggested by previous research (Ilgen et al., 2008). 
Ilgen et al. also found that 30% of patients seeking treatment for chronic pain reported suicidal 
ideation, 37% of patients receiving opioid therapy reported suicidal thoughts, over 20% chronic 
patients also disclosed lifetime suicide attempts made by them to their primary providers (2008). 
Some the studies also showed evidence of 2-3 times more suicidal ideation among patients with 
pain.  
Kuramoto et al. suggested that suicidal ideation does not vary between stages level of 
nonmedical prescription opioid use such as past two years use or past one-year use, but all levels 
of duration of opioid use are responsible for suicidal ideation (2011). Suicidal ideation is also 
affected by the withdrawal of opioids use, so continue monitoring for suicide is necessary among 
past and present opioids users. In the earlier research, there was a strong link between pain and 
suicide, so that also explains the connection between suicide and opioids users by stating most 
opioid users have chronic pain. Most of the national data such as NSDUH does not ask the direct 
question about pain in the reasons of for opioids use, so the only close causal relationship is 
possible between opioids-use and suicide is through statistically and analytically (Kuramoto et 
al., 2010). Neurobiological changes caused by opioids may be the mechanism by which opioid 
use is associated with suicidal ideation. Mood disorder is common among opioids users, and it is 
also one leading risk factor for suicidal planning and attempts (Kuramoto et al., 2010). 
Wilson, Compton, Nora, and Volkow suggested that dose, route of administration, co-
administration with other drugs, and the conditions text during opioids of use, and expectations 
from opioids use are critical to determining major risk factors for addiction and overdose (2006). 
Teenagers are at high risk for opioids addiction and its side effects such as sleep disorder and 
suicide. A clinical study done by Cheatle found that 32% patients with chronic pain reported 
suicide ideation (2011). Clinical interventions suggested that targeting sleep quality and pain 
coping techniques can reduce the potential of suicide among opioids users. There are certain 
high-risk characteristics such as alcohol dependence, past suicide attempts, suicidal ideation, 
poor social support, being unemployed, being divorced, suffering from chronic illness, and 
personal belonging loss that may increase the risk for suicide among opioids users (Cheatle, 
2011). Risk factors for suicide are very high in opioids populations that it suggests death from 
drug overdoses is not to reduce the pain, but some users tried to end their life with high dose 
intentionally (Cheatle, 2011).  The findings by Cheatle suggest that there is a need for 
determining the association between chronic pain and intentional self-harm for clinicians as 
guidelines before prescribing pain medicines (2011). Trémeau et al. found those suicide 
behaviors among opioid users also affected by the history of aggression and smoking (2008). 
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The family history of suicide was also responsible for suicide ideation, attempts, and planning.  
 
The Relationship between Sleep Disturbance and Suicidality 
 
Increasing evidence in research shows sleep disturbance significantly contribute to 
suicidal ideation, suicide attempts, and death by suicide (Bernert, Kim, Iwata, & Perlis, 2015). 
Depression and mental health disorder are significant implication to determine direct causal 
relationship between sleep and suicide.  Bernert et al. found that association between suicidal 
ideation, behaviors and sleep disturbance exist above and beyond from the depression, but there 
are not enough clinical studies about the relationship between sleep and suicide after controlling 
depression are available. Insomnia and other sleep disturbance risk factors also offer unique 
opportunity to prevent suicide by intervening risk factors (Bernert et al., 2015). Identifying risk 
factors for suicide-related to sleep disturbance can strengthen prevention of suicide and research 
in coordinated care in the medical world.   
Some of the common risk factors for suicide and sleep disturbance include history of 
childhood abuse, history of mental disorders, history of alcohol and substance abuse, aggressive 
behaviors, social and work isolation, fear of seeking help poor social support system, being 
unemployed, being divorced, suffering from chronic illness, and having psychiatric disorders 
(Cheatle, 2011).  Pigeon, Pinquart, and Conner (2012) suggested that depression did not 
moderate the association between insomnia and nightmares and suicidal thoughts and behavior 
from their meta-analysis research study.  Pigeon, Pinquart, and Conner (2012) study found 
smaller association after adjusting for depression, but the result was still significant for sleep and 
suicide relationship.  
Wong and colleagues also found in their study of adolescence that trouble sleeping is a 
strong predictor of subsequent suicide thoughts and self-harm behaviors (2011). Additional 
examination of disordered sleep and self-harm by the researchers, which controlled for gender, 
parental alcoholism and parental suicidal thoughts, and prior suicidal thoughts or self-harm 
behaviors among participants 12–14 years old in statistical modelling, determined that sleep 
difficulties/disturbances were predictive of suicidal thoughts and self-harm behaviors at ages 15–
17 (Wong, Brower, & Zucker, 2011). The research team also found that trouble sleeping is easier 
to assess in interviews among adolescence in their longitudinal study to determine the 
association between trouble sleeping and suicide (2011). The study also suggested future 
research for early intervention to reduce sleep problems and consequentially risk of suicide 
among adolescence.  
In a similar study conducted by McCall (2013), insomnia, hopelessness, and nightmares 
were found to be modifiable risk factors for suicide. Hopelessness was identified as the strongest 
risk factor for suicide because it was recognized as an independent factor that distinguishes 
individuals with depression that have suicide ideation from those without (McCall, 2013). 
Serotonin in the brain plays the major role in sleep-related problems, and low level of serotonin 
also known as to impair decision-making skills in individuals (McCall, 2013). Poor decision 
making choices about life leads to suicidal ideation from that. McCall (2011) findings about 
sleep and suicide association are somehow mediated by serotonergic mechanisms. While the 
clinical world focuses on controlling infectious disease outbreaks and risk reduction, suicide 
continues to rise as a global health threat. Prevention strategies to tackle problems sleep 
problems is necessary to stop the threat of suicide from that (McCall, 2011).  
Krakow, Ribeiro, Ulibarri, Krakow & Joiner (2011) found suicidal individuals reported 
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more sleep disturbances than non-suicidal individuals in their study sample of patients seeking 
services at a sleep center. This research has determined that suicidality is positively correlated 
with sleep problem severity and chronicity (Krakow et al., 2011). Scientific research is 
convincing that sleep disturbances is linked strongly with suicidal ideation-which reveals an 
important window of opportunity for investigation when examining patterns of risk specifically 
among opioid abusers.   
 
 Summary of literature and gaps in literature 
 
        According to Bernert and Joiner, suicide kills more Americans than homicides, and 
it is the 11th cause of death in the USA (2007). Suicidal behaviors and attempts have the 
significant impact on public health and health care cost because more than 400,000 emergency 
room visits are the result of suicidal ideations. Identification of risk factors for suicidal behaviors 
are necessary for successful prevention efforts to decrease suicidal attempts. Bryan and Rudd 
(2012) stated that acute suicidal ideation could resolve within few months, but chronic suicidal 
ideation involves greater severity of ideation and attempts.  Several studies also already 
suggested that acute and chronic suicidal ideation and attempts is associated with social, 
psychological, and biological variables (Bryan & Rudd, 2012). In the present research 
environment, there is also a need for identifying the link between sleep disturbances and suicidal 
ideation. The Substance Abuse and Mental Health Services Administration also listed sleep 
disturbance under top 10 warning signs of suicide. This study is necessary to understand 
relationships between pain, sleep disturbances, suicide and overdose deaths among opioids users.  
Bonar et all study also found the strong link between overdose history and opioids use (2014). 
The further analysis from NSDUH can provide the missing link between overdose deaths and 
opioids users by suggesting possible mechanisms sleep disturbances and suicidal ideation. The 
previous literature review suggested that suicidal ideation is greater among opioids users 
compared to non-users and people with withdrawal symptoms also have a greater risk. Increased 
rate of overdose deaths and opioids use in the USA also suggest scientific research to stop the 
harm among opioids users. Most of the studies found underlying risk factors for opioids users, 
but there is not a single study using national data such as NSDUH to explore the association 
between sleep disturbance and suicidal ideation among opioids users.  Pain is the significant 
factor for the lack of sleep, and suicidal ideation and most of the opioids users do suffer from 
pain. This research study will help providers to identify high risk for sleep disturbances leading 
to suicide and overdose deaths among opioids users. Interventions for risk factors among chronic 
pain patients can also help the population health by identifying and intervening possible risk 
factors and consequences of opioids use.  
 
Methods  
 
Study Design  
The NSDUH study (formerly the National Household Survey on Drug Abuse) was 
developed and first implemented in 1971, and is done periodically with the most recent ones in 
in 1979, 1982, 1985, 1988, and 1990 through 2014.  The Substance Abuse and Mental Health 
Services Administration's Center for Behavioral Health Statistics and Quality and Research 
Triangle Institute (RTI) International sponsor the NSDUH surveys.  RTI International also 
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conducts NSDUH surveys each year.  
The primary purpose of NSDUH is to measure the prevalence of drug use in the US. The 
survey includes several questions on mental health issues, illicit drugs use, alcohol, and tobacco 
among members of the US civilian and noninstitutionalized population ages 12 or greater. The 
NSDUH consists demographic items and questions about the tobacco, alcohol, marijuana, 
inhalants, cocaine, crack, cocaine, heroin, hallucinogens, pain relievers, tranquilizers, stimulants, 
and sedatives. Before 1999, the study was conducted using paper-and-pencil interviewing 
methods for an interview lasting about an hour.  
Prior to 1982, Health Statistics and Quality professionals went to participants’ homes and 
administered the surveys (after 1982, RTI nternational was selected to conduct the surveys).  
Initial surveys were about 3,000 respondents selected from 50 states in the earlier phase of 
NSDUH surveys. Participants completed substance use and other sensitive questions via paper 
and pencil, so the interviewer was not aware of answers. Less sensitive questions about 
demographics, occupational status, household size, and composition were asked aloud by the 
interviewer and recorded in the booklet.  
Since 1999, the interview has been conducted using computer-assisted methods. The 
survey uses a combination of computer-assisted personal interviewing conducted by an 
interviewer and audio computer-assisted self-interviewing by RTI professionals going to selected 
participants’ homes. Use of computer assisted methods is designed to provide respondents with a 
highly private and confidential means of responses to questions and to increase the level of 
honest reporting of illicit drug use and other sensitive behaviors.  
Computer assisted methods also created similar state level estimates to paper-pencil methods, but  
with a sample size of about 70,000 respondents per year from 50 states for NSDUH surveys each 
year.  
Since 1999, the survey sample has a 50-state design with an independent, multistage area 
probability sample. For 1999 through 2013, the eight states with the largest population were 
designated as large sample states with a target sample size of 3,600, while the remaining 42 
states and the District of Columbia had target sample of 900. From 2014 through 2017 the 
sample design has a more cost-efficient sample allocation to the largest states, while at the same 
time maintaining sufficient sample sizes in the smaller states to support small area estimation. 
Each NSDUH respondent since 2002 has been given an incentive of $30 in order to facilitate a 
larger response rate.  
 
Variables 
 
Opioid Abuse 
 
In order to assess non-medical prescription opioid use in the past year, participants were 
asked “How long has it been since you last used any prescription pain reliever that was not 
prescribed for you or that you took only for the experience or feeling it caused?” Respondents 
were presented with pictures and names of different types of prescription opioids and asked if 
they had used them non-medically (SAMHSA, 2014). Respondents were told to exclude over the 
counter pain relievers use. If the response indicated nonmedical use during the preceding 12 
months, the respondent was classified as a nonmedical prescription opioid user within the past 
year. The respondents were also asked the year and age in which they started using prescription 
opioids non-medically as well as asked about the time since last use and number of days of use.  
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Sleep Disturbance  
 
In order to assess sleep disturbance among abusers for this study, it was necessary to use 
two questions related to sleep disturbance. Sleep Disturbance for this study include questions 
about whether the respondent reported “having problems sleeping/waking early” and reported 
“having sleep problems” to get a better understanding of sleep disturbance among abusers. Two 
questions related to sleep disturbances were used in the analysis. There were six possible 
responses to two questions used for sleep disturbance in the study. Two different questions 
included same responses such as yes, no, don’t know, refused, and legitimate skip for survey 
participants. For this study’s main research question, only individuals who answered ‘yes’ were 
included in the results.  
 
Suicide Ideation, Planning, and Attempts 
 
 In order to assess suicidal ideation, participants were asked about whether, when their 
problems are worse, they (1) “think it would be better if they were dead” or (2) “think about 
committing suicide”.  In order to assess suicidal planning, participants were asked about their 
problems are worse, they (1) have “any thoughts or plans of suicide” or (2) “make a suicide 
plan.” In order to assess suicidal attempts, participants were asked about whether, when their 
problems are worse, they “make a suicide attempt.” Response options for all questions about 
suicidal ideation, planning, and attempts include “yes”, “no” or “don’t know”; participants could 
also refuse to answer or skip the question. As earlier stated, only individuals who answered ‘yes’ 
were included to find the association. 
 
Recent Mental Health Disorder 
 
In order to assess the presence of any recent diagnosed mental health disorders mental 
health disorders, participants were asked, “Received Any Mental Health Treatment in Past 
Year?”  Response options included “yes”, “no” or “unknown”. For this question, only 
individuals who answered ‘yes’ were included to control mental health disorders for the 
relationship between sleep disturbance and suicidal ideation, planning, and attempts.   
 
Data Analysis  
 
To better understand the association between suicidal ideation and sleep disturbance 
among opioids abusers, statistical analyses with NSDUH data were conducted using SAS 
software. Data analyses were done using single year analysis from 2010 to 2014. There is also 
time trend analysis done using all variables from 2010 to 2014 associated with the main question 
in this study. The first data analysis was conducted using SAS to assess whether sleep 
disturbance was associated with suicidal ideation, planning and attempts among opioid abusers 
for 2010- 2014. NSDUH is weighted sample, so comparison between years are not done.  
The 3-level model was used with logistic regression analysis. This analysis’ format was similar 
to a previous study that used NSDUH, but association among opioids users was done first time. 
Odd ratios and 95% confidence intervals were reported to present the result. SAS version 9.4 
was used for statistical analyses to find the odds among opioids abusers for sleep disturbance and 
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suicidal ideation, planning, and attempts. Due to the complex weighting samples, the SAS 
procedures PROC SURVEYFREQ and PROC SURVEYLOGISTIC were used. NOMACR 
option was used for each model to estimate results better. The level of significance in this work 
was set at α = 0.05.  
 
Results 
 
Table 1 shows the nonmedical prescription opioid use among other drug use, mental 
disorders, and demographic characteristics. To be consistent with previous published studies of 
NSDUH, some of the common demographic variables are included. There were more female 
than male participants that were associated with higher response rate in surveys from 2010 to 
2014. Tobacco use and hallucinogens did not have any missing data like other categories of drug 
use. Almost all of the demographic variables from 2010 to 2014 had similar number of counts 
for responses in a given category. Opioids abuse was higher in ages 18 to 25 years from all years 
2010 to 2014. A greater number of opioids abusers also reported tobacco, alcohol, and marijuana 
use in all years 2010 to 2014. 
Table 1 also includes recoded variables such as Sleep Disturbance, Suicidal Ideation, 
Suicidal Planning, and Suicidal attempt by using responses for the questions “when problems 
worst have problems sleeping/waking early sleep problems”, “when problems worst think it 
would be better if dead”, “when problems worst think about committing suicide”, “when 
problems worst make a suicide plan”, “when problems worst make a suicide attempt any 
thoughts or plans of suicide”, from NSDUH 2010 - 2014 surveys. Table 1 also provides 
frequency and percentage for any mental health treatment received by abusers in the past year.  
Table 2 presents results on the association between sleep disturbance and suicidal 
ideation among opioids abusers obtained from proc survey logistic method, adjusted by age, 
gender, and mental health disorder. The odds ratios across years 2010-2014 ranged from 0.898 to 
1.715. In Table 2, OR= 1.715 (CI: 95% 1.132 – 2.600) in 2013 unadjusted and OR= 1.671 (CI: 
95% 1.102– 2.533) in adjusted data in same years were significant among opioids abusers, and 
suggested higher odds of association between sleep disturbance and suicidal ideation.  Some 
positive odd ratio given in the table suggested higher odds of association between sleep 
disturbance and suicidal ideation among opioids abusers, but they were not significant.  
Table 3 presents results on the association between sleep disturbance and suicidal 
planning among opioids abusers obtained from proc survey logistic method, adjusted by age, 
gender, and mental disorder. The odds ratios across years 2010-2014 ranged from 0.843 to 1.707. 
In Table 3, OR= 1.570 (CI: 95% 1.048– 2.352) in 2011 unadjusted and OR= 1.531 (CI: 95% 
1.014– 2.313) in adjusted data in same years was significant among opioids abusers, and 
suggested higher odds of association between sleep disturbance and suicidal planning.  Some 
positive odd ratio given in the table suggested higher odds of association between sleep 
disturbance and suicidal planning among opioids abusers, but they were not significant enough. 
Odd Ratios were negative in year 2010 and 2013 in both unadjusted and adjusted data suggested 
negative association between sleep disturbance and suicidal planning among opioids abusers.   
Table 4 presents results on the association between sleep disturbance and suicidal 
attempts among opioids abusers obtained from proc survey logistic method, adjusted by age, 
gender, and mental disorder. The odds ratios across years 2010-2014 ranged from 0.909 to 2.030. 
In Table 4, OR= 2.030 (CI: 95% 1.038– 3.968) in 2012 adjusted data was significant among 
opioids abusers, and suggested higher odds of association between sleep disturbance and suicidal 
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attempts. Some positive odd ratio given in the table suggested higher odds of association 
between sleep disturbance and suicidal attempts among opioids abusers, but they were not 
significant. Odd Ratios were negative in 2013 both unadjusted and adjusted and in 2014 adjusted 
data suggested negative association between sleep disturbance and suicidal attempts among 
opioids abusers.   
   
Discussion  
 
Drug overdose by opioids is a major public health concern in recent time. Often time, it is 
very hard to determine intentional or unintentional overdose when overdose leads to death. It is 
important to understand the association between sleep disturbance and suicidal ideation because 
that can provide ways to intervene opioids use and decrease number of overdose deaths among 
abusers.  
Results from surveys in 2013 indicate sleep disturbance is associated with suicidal 
ideation among opioids abusers. Results from surveys in 2011 indicate strong association 
between sleep disturbance and suicidal planning among opioids abusers. Results from surveys in 
2012 among adjusted data indicate strong association between sleep disturbance and suicidal 
attempts among opioids abusers. These results are somewhat aligned with previous research 
described in literature review about opioids abusers having sleep problems, suicidal ideation, 
planning, and suicidal attempts.   
This research makes contributions by giving the understanding of higher odds of 
association for sleep disturbances and suicidal ideations, planning and attempts among opioids 
abusers using variables and responses given in 2010-2014 NSDUH data. Opioids epidemic is 
growing recently, but there are some research gaps for this topic. Knowledge of these research 
findings of the association can help early intervention and screening among opioids abusers and 
stop overdose deaths. 
One of the studies by Webster et al. found that methadone caused more opioid-related 
deaths than any other opioids due to physician knowledge gaps, patient nonadherence to other 
medicines, medical and mental health comorbidities, other substance use, and payer policies that 
mandate methadone as first-line therapy (2011). Opioids related deaths are multifactorial, so 
solutions should include all of the factors to decrease harm among people. This research study’s 
association results should be taken into consideration for risk evaluation and harm reduction 
strategies among opioids abusers.  
Another study by Paulozzi and Xi also suggested that opioids use is not the urban 
problem anymore, but increased opioids treatment also resulted in more abuse in rural areas in 
the USA (2008). This study makes one major contribution by assessing sleep disturbance and 
suicidal ideation, planning, and attempts among opioid abusers. The study’s findings of higher 
odds of association between sleep disturbance, suicidal ideation, suicidal planning, and attempts 
are consistent with previous studies mentioned before about association between sleep problems 
and suicide. There is no other study published to show the association between sleep disturbance, 
suicidal ideation, suicidal planning and attempts among opioids abusers, so this finding adds 
value to public health research. National Survey on Drug Use and Health from 2010 to 2014 did 
not show a higher prevalence of nonmedical use of pain relievers, and that could be one of the 
limitations for not getting significant results.  
 In order to assess the sleep disturbance and suicidal ideation, planning, and attempts 
among opioid abusers, a longitudinal study needs to be designed to assess the progression of 
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sleep disturbance and suicidal ideation, planning, and attempts among opioid abusers over time. 
Such a study could identify risk factors associated with sleep and suicide among opioid abusers. 
Strategies for preventing progression across sleep disturbance and suicidal ideation, planning, 
and attempts among opioid abusers will be invaluable findings. More research can help to find 
risk factors and achieve overall mission of harm reduction among opioids abusers.  
  
Strengths and Limitations of studies by NSDUH 
 
NSDUH is the national representative sample of annual estimate about drug use and 
mental illness among the noninstitutionalized population in the US. Most of the questions in 
NSDUH administered with computer assisted methods, which is designed to provide the private 
and confidential mode for respondents. It is also intended to increase the level of honest 
reporting of illicit drug use and other sensitive behaviors. Also, the large and dispersed NSDUH 
sample enables not only state-level estimates but also estimates for sub-state levels. NSDUH is 
useful for many purposes, but it has some limitations. The data are self-reports, and thus the 
validity of the data depends on respondents' truthfulness and accurate memory about drug use 
and other topics. Some experimental studies suggested the validity of self-reported data and 
NSDUH procedures were designed to encourage honesty and recall among participants. Some 
underreporting and over reporting is seen in surveys.  Underreporting and over reporting were 
recoded by RTI international professionals according to answers given by individuals in similar 
questions asked during surveys.  
Second, the survey is cross-sectional rather than longitudinal. In this survey, individuals 
were interviewed only once and were not followed for additional interviews in subsequent years. 
Each year's survey provides an overview of drug use prevalence at a particular point in time 
rather than how drug use changes over time for the specific group of people. That means we 
cannot make casual interpretation between sleep disturbance and suicidal ideation, planning or 
attempts among opioids abusers.  
Third, because the target population of the survey is defined as the civilian, 
noninstitutionalized population of the US, a small proportion of the population is excluded. The 
subpopulations excluded are the homeless, members of the active-duty military and individuals 
in institutional settings. If excluded populations are opioids abusers with higher odds of 
association between sleep disturbance and suicidal ideation, planning or attempts, it is missing 
useful data for this study and non-generalizable results.  
There was a considerable amount of missing responses for opioid use, suicide and sleep 
related questions. Variables were categorized for responses to understand frequency percentage 
related to this study. All study variables considered in this analysis were categorical. These 
results are displayed in Table 1 for 2010 to 2014. The main reason for not getting any significant 
results in years 2010 and 2014 was that those years had slightly low frequency in endorsements 
for suicide and sleep related questions included in the SAS analysis. According to Page (2014), 
the presence or absence of statistically significant differences has limited value in terms of 
accepting or rejecting hypothesis. A non‐significant results for the association between sleep 
disturbance and suicidal ideation among opioids abusers during some of the years does not really 
imply that the findings is not effective because the presence or absence of statistically significant 
is affected by the heterogeneity of samples, small sample sizes and measurement variability and 
limitations on hypothesis testing for the research (Page, 2014).  
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Conclusion 
 
In summary, this research described the association between sleep disturbances and 
suicidal ideation, planning and attempts among opioids abusers. Some significant results from 
2011, 2012, and 2013 years indicate a risk for sleep disturbance and suicidal ideation, planning 
or attempts among opioids abusers. Not all years’ data unadjusted and adjusted were significant, 
so we cannot suggest greater association between sleep and suicide problems among opioid 
abusers to be able to generalize. This paper still provides future direction to find the association 
using data where the prevalence of opioids uses, sleep problems, and suicidal problems are high. 
This study’s findings can also be beneficial for educational and public health prevention 
programs to promote a better understanding of sleep disturbance, suicidal ideation, planning, and 
attempts among opioid abusers. 
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Table 1:  Prevalence of opioids abusers by demographic characteristics, NSDUH 2010- 2014 
 Years  
N (%) 
Characteristics  Category 2010 
Reported 
opioids Abuse 
(N=9120) 
2011 
Reported 
opioids Abuse 
(N=9082) 
2012 
Reported 
opioids Abuse 
(N=8674) 
2013 
Reported 
opioids Abuse 
(N=8094) 
2014 
Reported 
opioids Abuse 
(N=7966) 
Age  12-17 
Years Old 
1684 
18.5% 
1709 
18.8% 
1490 
17.2% 
1342 
16.58% 
1001 
12.6% 
 18-25 
Years Old 
4498 
49.3% 
4425 
48.7% 
4192 
48.3% 
3852 
47.6% 
2621 
32.9% 
  26-34 
Years Old 
1277 
14% 
1259 
13.9% 
1315 
15.2% 
1234 
15.2% 
1842 
21.3% 
 35-49 
Years Old 
1250 
13.7% 
1162 
12.8% 
1177 
13.6% 
1162 
14.4% 
1698 
8.4% 
 50-64 
Years Old 
356 
3.9% 
463 
5.1% 
464 
5.3% 
426 
5.3% 
668 
1.7% 
 65 or 
Older 
55 
0.6% 
64 
0.7% 
66 
0.8% 
78 
0.9% 
136 
52.6% 
Gender Male 4738 
51.9% 
4842 
53.3% 
4560 
52.6% 
4082 
50.4% 
4191 
47.4% 
 Female 4382 
48.1% 
4240 
46.7% 
4114 
47.4% 
4012 
49.6% 
3775 
81.2% 
Tobacco Use Yes  7570 
83% 
7461 
82.1% 
7035 
81.1% 
6521 
80.6% 
6466 
18.8% 
 No  1550 
17% 
1621 
17.8% 
1639 
18.9% 
1573 
19.4% 
1500 
93.1% 
Alcohol  Yes 8516 
93.4% 
8460 
93.1% 
8049 
92.8% 
7506 
92.7% 
7415 
6.9% 
  No 603  
6.6% 
622 
6.8% 
625 
7.2% 
588 
7.3% 
550 
83.3% 
Marijuana Yes 7197 
78.9% 
7165 
78.9% 
6840 
78.9% 
6354 
78.5% 
6636 
20.4% 
  No 1917 
21% 
1911 
21% 
1826 
21.1% 
1737 
21.5% 
1628 
12.8% 
Cocaine Yes 3478 
38.1% 
3444 
37.9 
3296 
38% 
2925 
36.1% 
1022 
87.1% 
 No 5636 
61.8% 
5632 
62% 
5373 
61.94% 
5167 
63.8% 
6941 
12.8% 
Heroin  Yes 597 
6.5% 
651 
7.2% 
656 
7.6% 
655 
8.1% 
750 
90.5% 
 No 8518 
93.4% 
8428 
92.8% 
8013 
92.4% 
7433 
91.8% 
7212 
45.7% 
Hallucinogens  Yes 
 
4198 
46% 
4121 
45.4% 
3891 
44.9% 
3590 
44.3% 
3637 
54.3% 
 No 4922 
53.1% 
4961 
54.6% 
4783 
55.1% 
4504 
55.6% 
4329 
26.6% 
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Table 1:  Prevalence of opioids abusers by demographic characteristics, NSDUH 2010- 2014 
 Years 
N (%) 
Characteristics  Category 2010 
Reported 
opioids 
Abuse 
(N=9120) 
2011 
Reported 
opioids 
Abuse 
(N=9082) 
2012 
Reported 
opioids 
Abuse 
(N=8674) 
2013 
Reported 
opioids 
Abuse 
(N=8094) 
2014 
Reported 
opioids 
Abuse 
(N=7966) 
Inhalants  Yes 2710 
29.7% 
2474 
27.2% 
2340 
26.9% 
2087 
25.8% 
2117 
73.3% 
 No 6400 
70.2% 
6603 
72.7% 
6319 
72.8% 
5989 
74% 
5836 
4.3% 
Tranquilizers  Yes 365 
4% 
359 
3.9% 
353 
4.1% 
3292 
40.7% 
342 
56.6% 
  NEVER USED 
TRANQUILIZERS  
5440 
59.6% 
5467 
60.2% 
5116 
58.9% 
4782 
59.1% 
4512 
28.5% 
Stimulants  Yes 2452 
26.9% 
2381 
26.2% 
2263 
26.1% 
2190 
27.1% 
2269 
71.1 
  NEVER USED 
STIMULANTS  
6638 
72.8% 
6671 
73.4% 
6386 
73.6% 
5880 
72.6% 
5664 
8.5% 
Sedatives Yes 685 
7.5% 
658 
7.2% 
610 
7.1% 
585 
7.2% 
676 
91.1% 
  NEVER USED 
TRANQUILIZERS  
8402 
92.1% 
8393 
92.4% 
8026 
92.5% 
7478 
92.4% 
7258 
20.1% 
Mental Health 
Disorder 
Health 
 Yes  1599 
21.6% 
1492 
20.3% 
1587 
22.2% 
1499 
22.3% 
1620 
23.4% 
  No  5803 
78.4% 
5845 
79.7% 
5568 
77.8% 
5214 
77.7% 
5306 
76.6% 
Sleep 
Disturbance 
Yes 1528 
16.7% 
1548 
17.0% 
1567 
18.0% 
1515 
18.7% 
1479 
18.6% 
Suicidal 
Ideation 
 
Yes 789 
8.6% 
780 
8.6% 
837 
9.6% 
796 
9.8% 
759 
9.5% 
Suicidal 
Planning 
Yes 759 
2.5% 
800 
8.8% 
814 
9.4% 
797 
9.8% 
746 
9.4% 
Suicidal 
Attempt 
Yes 228 
2.4% 
250 
2.7% 
288 
3.3% 
249 
3.0% 
240 
3.0% 
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Table 2: Association between sleep disturbance and suicidal ideation among opioids abusers 
 
*Adjusted for age, gender & mental health disorders 
** p<0.05 
***p<0.01 
 
 
Table 3: Association between sleep disturbance and suicidal planning among opioids abusers 
 
 
 
 
2010 2011 2012 2013 2014 
Unadjusted 
OR (95% 
CI) 
 
Adjusted* 
OR (95% 
CI) 
 
Unadjusted 
OR (95% 
CI) 
 
Adjusted* 
OR (95% 
CI) 
 
Unadjusted 
OR (95% 
CI) 
 
Adjusted* 
OR (95% 
CI) 
 
Unadjusted 
OR (95% 
CI) 
 
Adjusted* 
OR (95% 
CI) 
 
Unadjusted 
OR (95% 
CI) 
 
Adjusted* 
OR (95% 
CI) 
 
0.974 
(0.618, 
1.535) 
0.943 
(0.590,  
1.506) 
1.570** 
(1.048, 
2.352) 
1.531** 
(1.014, 
2.313) 
1.675 
(0.980, 
2.865) 
1.707 
(0.981, 
2.969) 
0.843 
(0.527, 
1.349) 
0.817 
(0.531, 
1.257) 
1.364 
(0.939, 
1.980) 
1.318 
(0.910, 
1.908) 
*Adjusted for age, gender & mental health disorders 
** p<0.05 
***p<0.01 
 
 
 
Table 4: Association between sleep disturbance and suicidal attempts among opioids abusers 
 
*Adjusted for age, gender & mental health disorders 
** p<0.05 
***p<0.01 
 
2010 2011 2012 2013 2014 
Unadjusted 
OR (95% CI) 
 
Adjusted* 
OR (95% 
CI) 
 
Unadjusted 
OR (95% 
CI) 
 
Adjusted* 
OR (95% 
CI) 
 
Unadjusted 
OR (95% 
CI) 
 
Adjusted* 
OR (95% 
CI) 
 
Unadjusted 
OR (95% 
CI) 
 
Adjusted* 
OR (95% 
CI) 
 
Unadjusted 
OR (95% 
CI) 
 
Adjusted* 
OR (95% 
CI) 
 
1.309 
(0.869,1.974) 
 
1.213 
(0.803, 
1.833) 
1.507 
(0.743, 
1.504) 
1.070 
(0.774, 
1.480) 
1.229 
(0.764, 
1.975) 
1.184 
(0.736, 
1.904) 
1.715*** 
(1.132, 
2.600) 
1.671** 
(1.102, 
2.533) 
0.950 
(0.688, 
1.312) 
0.898 
(0.640, 
1.260) 
2010 2011 2012 2013 2014 
Unadjust
ed 
OR 
CI 
Adjusted* 
OR 
CI 
Unadjuste
d 
OR 
CI 
Adjusted
* 
OR 
CI 
Unadjuste
d 
OR 
CI 
Adjusted* 
OR 
CI 
Unadjuste
d 
OR 
CI 
Adjusted* 
OR 
CI 
Unadjuste
d 
OR 
CI 
Adjusted* 
OR 
CI 
1.119 
(0.596, 
2.102) 
 
 
1.084 
(0.559, 
2.102) 
1.651 
(0.907, 
3.005) 
1.555 
(0.856, 
2.826) 
1.924 
(0.986, 
3.755) 
2.030** 
(1.038, 
3.968) 
0.692 
(0.367, 
1.305) 
0.683 
(0.380, 
1.231) 
1.034 
(0.553, 
1.936) 
0.909 
(0.490, 
1.685) 
